FSWA
HZNP

Financial Synergies Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Financial Synergies Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$1.48K – 573
2023
Q4 		$1.48K Hold
13
– – ﹤0.01% 277
2023
Q3 		$1.5K Hold
13
– – ﹤0.01% 333
2023
Q2 		$1.34K Hold
13
– – ﹤0.01% 333
2023
Q1 		$1.42K Hold
13
– – ﹤0.01% 338
2022
Q4 		$1.48K Sell
13
-11
-46% -$914 ﹤0.01% 277
2022
Q3 		$1.49K Buy
24
+20
+500% +$1.4K ﹤0.01% 251
2022
Q2 		$320 Buy
+4
New +$379 ﹤0.01% 436

Other funds holding HZNP

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Financial Synergies Wealth Advisors's HZNP Position: Q1 2024 in Review

Financial Synergies Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2024, closing a stake of 13 shares — an estimated $1.48K sold.

Financial Synergies Wealth Advisors first reported a position in HZNP in Q2 2022 and held it in 7 quarters. The position peaked at $1.5K in Q3 2023. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2024.

  • Financial Synergies Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2024 after selling out during the quarter.
  • Financial Synergies Wealth Advisors sold 13 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2024, an estimated $1.48K.
  • Financial Synergies Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 7 quarters.
  • Financial Synergies Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.5K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2024.

Based on Financial Synergies Wealth Advisors's 13F filing for Q1 2024, filed 12 Apr 2024.